Generate a tailored SOP for Dr. Michael Macklin. Improve your application with a focused, well-structured draft.
Michael Macklin, MD, is an Assistant Professor of Medicine at the University of Chicago. He specializes in the treatment of patients with systemic sclerosis (scleroderma) and interstitial lung diseases (ILD). Dr. Macklin directs the multidisciplinary Scleroderma Program at the University of Chicago, working with specialists from various fields, including Pulmonary, Cardiology, Gastroenterology, Plastic Surgery, and Dermatology, to provide comprehensive care for individuals diagnosed with systemic sclerosis. His clinical research focuses on improving diagnosis and treatment, particularly through clinical trials involving CAR-T cell therapy for systemic sclerosis. Additionally, Dr. Macklin is an active member of the multidisciplinary ILD group at the University of Chicago that hosts a combined rheumatology-pulmonary clinic dedicated to patients with ILD due to autoimmune diseases. His work in ILD has gained international recognition for innovative research and clinical trials. He is also involved in the multidisciplinary IgG4 Clinical Consortium at the University of Chicago, which includes specialists in various medical fields, and is passionate about medical education, working with learners at all stages of their training.
Department of Philosophy